Q3 2026 13F filing
Updated 6 days ago47 disclosed positions worth $1.2B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | T TANGO THERAPEUTICS INC | $262.6M | 10.53M | 22.82% | — |
| 2 | K KODIAK SCIENCES INC | $140.1M | 1.48M | 12.17% | — |
| 3 | R REVOLUTION MEDICINES INC | $102.6M | 500.0K | 8.92% | — |
| 4 | K KYMERA THERAPEUTICS INC | $58.6M | 524.6K | 5.10% | — |
| 5 | Q REPLIMUNE GROUP INC | $56.6M | 4.28M | 4.92% | — |
| 6 | A ABIVAX SA | $47M | 475.0K | 4.09% | — |
| 7 | S SURROZEN INC | $43.8M | 1.36M | 3.81% | — |
| 8 | C CORCEPT THERAPEUTICS INC | $38.7M | 335.5K | 3.36% | — |
| 9 | P PRECIGEN INC | $37M | 4.32M | 3.21% | — |
| 10 | Q UNIQURE NV | $34.4M | 1.42M | 2.99% | — |
| 11 | D DEFINIUM THERAPEUTICS INC | $26M | 683.6K | 2.26% | — |
| 12 | A AMYLYX PHARMACEUTICALS INC | $26M | 893.2K | 2.26% | — |
| 13 | S SPYRE THERAPEUTICS INC | $25.2M | 283.1K | 2.19% | — |
| 14 | P PROTAGONIST THERAPEUTICS INC | $24M | 170.0K | 2.08% | — |
| 15 | C CELCUITY INC | $22.8M | 286.2K | 1.98% | — |
| 16 | I OPUS GENETICS INC | $21.9M | 4.53M | 1.91% | — |
| 17 | Q Q32 BIO INC | $21.3M | 2.58M | 1.85% | — |
| 18 | U UROGEN PHARMA LTD | $20.3M | 500.0K | 1.77% | — |
| 19 | A ACHIEVE LIFE SCIENCE INC | $17.4M | 2.15M | 1.51% | — |
| 20 | B C4 THERAPEUTICS INC | $13.8M | 4.15M | 1.20% | — |
| 21 | T FIRST TRACKS BIOTHERAPEUTICS | $8.5M | 240.0K | 0.74% | — |
| 22 | S SHATTUCK LABS INC | $8M | 1.18M | 0.70% | — |
| 23 | S SAB BIOTHERAPEUTICS INC | $7.9M | 2.50M | 0.69% | — |
| 24 | C CULLINAN THERAPEUTICS INC | $6.9M | 450.0K | 0.60% | — |
| 25 | C CONTINEUM THERAPEUTICS INC | $6.6M | 494.0K | 0.58% | — |
| 26 | C CYTOKINETICS INC | $6.6M | 100.0K | 0.57% | — |
| 27 | ? N/A PALISADE BIO INC | $6.5M | 4.80M | 0.56% | — |
| 28 | C CAPRICOR THERAPEUTICS INC | $6.1M | 642.8K | 0.53% | — |
| 29 | ? N/A ELECTRA THERAPEUTICS INC | $5.1M | 450.0K | 0.44% | — |
| 30 | ? N/A AN2 THERAPEUTICS INC | $5M | 944.0K | 0.44% | — |
| 31 | M MAZE THERAPEUTICS INC | $4.8M | 175.5K | 0.41% | — |
| 32 | ? N/A EDESA BIOTECH INC | $3.9M | 937.4K | 0.34% | — |
| 33 | R RELAY THERAPEUTICS INC | $3.6M | 200.0K | 0.31% | — |
| 34 | K KAZIA THERAPEUTICS LTD | $3.6M | 371.5K | 0.31% | — |
| 35 | ? N/A ATTOVIA THERAPEUTICS INC | $3.4M | 200.0K | 0.30% | — |
| 36 | P PMV PHARMACEUTICALS INC | $3.4M | 2.05M | 0.30% | — |
| 37 | ? N/A CRESCENT BIOPHARMA INC. | $3.3M | 226.8K | 0.29% | — |
| 38 | ? N/A ZENTALIS PHARMACEUTICALS INC | $2.8M | 1.01M | 0.24% | — |
| 39 | S SAREPTA THERAPEUTICS INC | $2.7M | 150.0K | 0.24% | — |
| 40 | A ALLOGENE THERAPEUTICS INC | $2.4M | 1.50M | 0.21% | — |
| 41 | N NURIX THERAPEUTICS INC | $2.4M | 100.0K | 0.21% | — |
| 42 | S SIONNA THERAPEUTICS INC | $2.1M | 391.7K | 0.18% | — |
| 43 | C CLENE INC | $1.9M | 477.5K | 0.17% | — |
| 44 | A ACLARIS THERAPEUTICS INC | $1.6M | 300.0K | 0.14% | — |
| 45 | M MILESTONE PHARMACEUTICALS IN | $577K | 666.7K | 0.05% | — |
| 46 | N NEUMORA THERAPEUTICS INC. | $569K | 954.1K | 0.05% | — |
| 47 | K KARYOPHARM THERAPEUTICS INC | $156K | 127.5K | 0.01% | — |